279 results
Page 2 of 14
8-K
EX-99.1
yc15wfl3ext
3 May 23
BioCryst Reports First Quarter 2023 Financial Results and Provides Business Update
7:08am
8-K
EX-99.1
ubejer 3gqbli
15 Dec 22
BioCryst Discontinues Development of BCX9930 and Shifts Focus to Potential Once-daily, Oral Factor D Inhibitor, BCX10013
7:03am
8-K
EX-99.1
kdqdspaj 2ac15o0xo8
1 Nov 22
BioCryst Reports Third Quarter 2022 Financial Results and Upcoming Key Milestones
7:06am
8-K
EX-99.1
uh5ub
14 Sep 22
BioCryst Names Dr. Bill Sheridan Chief Development Officer and Appoints Dr. Ryan Arnold Chief Medical Officer
4:08pm
8-K
oqoeouup42lg
14 Sep 22
BioCryst Names Dr. Bill Sheridan Chief Development Officer and Appoints Dr. Ryan Arnold Chief Medical Officer
4:08pm
8-K
EX-99.1
f4gl5mnx1g27vpzxr0
4 Aug 22
BioCryst Reports Second Quarter 2022 Financial Results and Upcoming Key Milestones
7:06am
8-K
EX-99.1
j5g0b
5 May 22
BioCryst Reports First Quarter 2022 Financial Results and Upcoming Key Milestones
7:05am
8-K
EX-99.1
bzjo3rplh0phu7 fdp
23 Feb 22
BioCryst Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Key Milestones
7:02am
8-K
EX-99.1
ummw4y4 egw
10 Jan 22
Results of Operations and Financial Condition
7:04am